A recent market analysis offers a promising outlook for contract fill-finish and lyophilization services.

Catalent has acquired Relthy Laboratorios in Brazil to expand its South American softgel technology business.

ABC Laboratories plans to move operations of its subsidiary, Morse Laboratories, based in California, to Missouri.

Pfenex modifies its contract with US government for Anthrax vaccine.

AMRI has been awarded a seven-year contract for an active ingredient under clinical evaluation.

Carbogen Amcis has made several investments to increase capabilities in supplying antibody drug conjugates.

Hovione's plant in Portugal has successfully passed its twelfth FDA inspection in 18 months.

3M Drug Delivery will manufacture transdermal patch for ProStrakan.

United Drug's Packaging division rebrands as Sharp Packaging.

The Waters ACQUITY QDa Detector is a mass detector designed to bring high-quality, mass spectral data to chromatographic separations.

During the ongoing federal government shutdown, FDA activities will be limited to work involving the safety of human life or the protection of property, and activities funded by carryover user fee balances PDUFA, GDUFA, and MDUFA.

Advanced Biosciences Laboratories will support the development and production of a novel Shigella vaccine candidate for PATH.

The sterile injectable manufacturer Ben Venue decides to end production despite efforts to remediate cGMP violations.

The US Department of Health and Human Services awards contract to four companies for Fill–Finish manufacturing for pandemic influenza vaccines.

Budget issues and changing global markets are prompting FDA to revise its growing network of overseas offices.

Malvern Instruments has acquired NanoSight, the UK-based nanoparticle characterization company.

he CMO Gallus BioPharmaceutical has acquired the biologics CMO Laureate Biopharmaceutical Services.

The first part of CPhI’s Annual Expert Industry Report examines ADCs, single-use technology, and regulatory failure.

Ireland?s life-sciences sector has grown significantly since the 1960s. To gain insights into the competitive edge that Ireland offers to the pharmaceutical industry, Pharmaceutical Technology Europe spoke with Barry Heavey from IDA Ireland, which is a government agency responsible for attracting pharmaceutical and biotech companies to Ireland.

The pharmaceutical industry grows despite conflict in the Middle East.

GlaxoSmithKline?s sale of its thrombosis brands is part of a focus on its late-stage pipeline.

Fujifilm Diosynth Biotechnologies? new mammalian cell-culture facility uses primarily single-use technologies.

USP seeks input from stakeholders on new and revised standards to mitigate extractables and leachables in plastic packaging systems.

Foreign companies zero in on Myanmar with the hope of securing a foothold in its pharmaceutical market.

Cambridge Major Laboratories and AAIPharma Services plan to merge to form a global supplier of integrated CMC services.

The rapid uptake of single-use vessels for use in bioprocessing applications has made assuring integrity that much more crucial; helium integrity testing can be used to test integrity and prevent failures.

Through its educational and networking opportunities, the American Association of Pharmaceutical Scientists plays an important role in partnering throughout the drug- development and commercialization process.

Contract service providers position in China as biopharmaceutical and pharmaceutical companies align their strategies in emerging markets for growth.